Advaxis Stock Price (NASDAQ:ADXS)

Add to My Stocks
$6.87 $0.08 (1.18%) ADXS stock closing price Jul 25, 2017 (Closing)
Prev Close* : $6.79
Market Cap:
$274.74M
Day Low: $6.62
52 Week Low: $5.70
Open: $6.83
Volume: 391285
Day High: $6.91
52 Week High: $16.30
Dividend:
N/A

Latest Stock Market News

Latest Articles

Advaxis News - From Partners

ADXS Stockcharts

View ADXS PE ratio, PS ratio stocks charts and compare with peers.
ADXS Chart
Note: Compare Advaxis stock price history with the index and industry peers.

Advaxis Valuation

PS ratio (
price to sales ratio
)
25.26
PB ratio (
price to book ratio
)
2.78

Advaxis Financial Ratios

Asset Turnover
0.1
Receivables Turnover
7.75

ADXS Industry Peers

Company Price Change (%)
Ambit Biosciences (AMBI)15.60 (0%)
Organovo (ONVO)2.390.01 (0.42%)
Aratana Therapeutics (PETX)7.250.12 (1.68%)
Astrazeneca (AZN)33.780.07 (0.21%)
Aduro Biotech (ADRO)13.70.25 (1.79%)
Inovio Pharma (INO)5.970.01 (0.17%)
Agenus (AGEN)5.140.23 (4.28%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Advaxis, Inc. Stock News - Partner Headlines

Advaxis Financial Statements

income statement20162015201420132012
Net Sales Or Revenues3.99M-1M--
Net Income-73.55M-47.03M-16.52M-19.98M-12.06M
Total Operating Expense80.48M48.67M20.53M14.69M12.32M
view Advaxis, Inc. income statement
balance sheet20162015201420132012
Total Assets169.04M119.6M23.37M23.58M3.81M
Total Liabilities49.74M4M2.74M5.58M9.77M
Shareholders Equity119.3M115.59M20.62M18M-5.96M
view Advaxis, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities39.85M1.02M-4.54M-0.27M5.87M
Net Cash From (Used By) Operating Activities-9.07M-24.13M-17.02M-8.71M-4.56M
Increase (Decrease) In Prop Plant And Equipment-3.22M-0.97M-0.02M-0.02M-0.09M
view Advaxis, Inc. cashflow statement

Advaxis Stock Message Board

An investor needs to spend 6.87 to buy ADXS stock, as the closing Advaxis stock price is 6.87. Looking at Advaxis market capitalization, which currently stands at 274.74M, we can say that ADXS stock is a Micro cap stock. Advaxis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Advaxis stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 391285 ADXS shares were traded yesterday, and Advaxis stock chart shows that the ADXS stock quote hit a day high of 6.91 and day low of 6.62. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Advaxis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.